ADVERTISEMENT
4 /5 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Start-ups

Kronos Bio launches with $18 million

by Ryan Cross
May 27, 2018 | APPEARED IN VOLUME 96, ISSUE 22

 

Hardly a month after retiring as chief scientific officer of Gilead Sciences, Norbert Bischofberger is leading a new company called Kronos Bio, which has announced raising $18 million in seed financing. The Cambridge, Mass.-based start-up will use small-molecule microarrays refined by Kronos’s scientific founder and MIT chemist Angela Koehler to discover compounds that modulate or degrade traditionally tough-to-target proteins implicated in cancer.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment